NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of four blue triangles facing inward to form a circle containing a stylized lowercase letter "T". There is a blue circle in the center of the four triangles. The color white serves as background areas and is not claimed as a feature of the mark.
Titulares
Representantes
Andrew S. Ehard
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of cancer; Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; Contrast media for use with medical equipment; Diagnostic agents for medical use in in vivo scanning; Compositions for medical use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, cancer; Chemicals for pharmaceutical use for the treatment, prevention, or diagnosis of cancer
Classe 9
Downloadable computer operating software; Downloadable computer application software for mobile phones, portable media players, and handheld computers, namely, software for the treatment, prevention, or diagnosis of cancer; Software as a Medical Device (SaMD), downloadable, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for medical purposes, namely, for the treatment, prevention, or diagnosis of cancer; Downloadable computer programs for the treatment, prevention, or diagnosis of cancer
Classe 10
Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; medical apparatus for use in laparoscopy; Medical apparatus for detecting cancer; Surgical instruments and apparatus; detecting instruments for medical use for detecting cancer; Medical instruments for use in the treatment, prevention, or diagnosis of cancer; Test equipment for medical use, namely, medical diagnostic instrument for cancer; diagnostic imaging apparatus for medical use; medical imaging apparatus; Probes for medical purposes; surgical instruments in the nature of surgical probes; surgical robots; nanorobots for medical purposes for surgical use
Classe 42
Software as a service (SAAS) services featuring software for the treatment, prevention, or diagnosis of cancer; computer software design; computer software development; computer software programming services for others in the field of medicine; development of software for the treatment, prevention, or diagnosis of cancer; Software as a service (SAAS) services, namely, hosting software for use by others for the treatment, prevention, or diagnosis of cancer; installation of computer software; software creation in the nature of computer software design; software engineering services; Design and writing of computer software; online provision of web-based applications, namely, providing temporary use of on-line non-downloadable applications for the treatment, prevention, and diagnosis of cancer; online provision of web-based software, namely, providing temporary use of online non-downloadable software for the treatment, prevention, or diagnosis of cancer; Consultancy in the field of artificial intelligence technology; research in the field of artificial intelligence technology
Classe 44
Medical analysis services for the diagnosis and treatment of persons with cancer; medical analysis services relating to the treatment of persons; medical diagnostic services; medical health assessment services; services for the preparation of medical reports, namely, providing medical information to patients, in the form of reports in the field of cancer; advisory services relating to medical services; consultancy and advisory services in relation to medical services; provision of medical information; Consulting services in the field of healthcare; health screening services in the field of cancer; providing information relating to health care services; preparation of reports relating to health care matters for medical purposes
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
NEW REPRESENTATIVE AT IB RECEIVED
30/07/2026
NEW REPRESENTATIVE AT IB RECEIVED
22/01/2026
NEW REPRESENTATIVE AT IB RECEIVED
01/01/2026
FINAL DECISION TRANSACTION PROCESSED BY IB
05/12/2025
FINAL DISPOSITION NOTICE SENT TO IB
15/11/2025
FINAL DISPOSITION PROCESSED
14/11/2025
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/07/2025
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
13/06/2025
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/05/2025
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/05/2025
NOTICE OF REGISTRATION CONFIRMATION EMAILED
29/04/2025
REGISTERED-PRINCIPAL REGISTER
29/04/2025
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2025
PUBLISHED FOR OPPOSITION
11/03/2025
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/03/2025
ASSIGNED TO LIE
18/02/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
13/02/2025
EXAMINER'S AMENDMENT ENTERED
13/02/2025
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/02/2025
EXAMINERS AMENDMENT E-MAILED
13/02/2025
EXAMINERS AMENDMENT -WRITTEN
13/02/2025
PREVIOUS ALLOWANCE COUNT WITHDRAWN
13/02/2025
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/02/2025
APPROVED FOR PUB - PRINCIPAL REGISTER
27/01/2025
EXAMINER'S AMENDMENT ENTERED
27/01/2025
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/01/2025
EXAMINERS AMENDMENT E-MAILED
27/01/2025
EXAMINERS AMENDMENT -WRITTEN
27/01/2025
ASSIGNED TO EXAMINER
26/01/2025
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2024
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/10/2024
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2024
REFUSAL PROCESSED BY IB
01/05/2024
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/04/2024
REFUSAL PROCESSED BY MPU
06/04/2024
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/03/2024
NON-FINAL ACTION WRITTEN
18/03/2024
ASSIGNED TO EXAMINER
14/03/2024
APPLICATION FILING RECEIPT MAILED
02/01/2024
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/12/2023
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/12/2023
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.